Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2000;9(5):377-81.

Systemic lupus erythematosus: mortality and survival in Argentina. A multicenter study

V Bellomio  1 , A Spindler, E Lucero, A Berman, M Santana, C Moreno, R P Hidalgo, S Paira, C Graf, J A Maldonado Cocco, G Citera, M S Arriola, G Gómez, J C Barreira, O Messina, C Asnal, D Carrillo, A Gervilla, L García, M Máscolo, D De la Sota M, G Rosso, L F Somma, R F Sosa, O Rillo, J A Caracciolo, G Lancioni, A Gómez
Affiliations
  • PMID: 10878732
Multicenter Study

Systemic lupus erythematosus: mortality and survival in Argentina. A multicenter study

V Bellomio et al. Lupus. 2000.

Abstract

Objective: To analyze the factors associated with mortality, survival and causes of death in patients with systemic lupus erythematosus (SLE) in Argentina.

Patients and method: A series of 366 patients with SLE (45 men and 321 women), mean age 29 y (range 11-70 y) and mean disease duration 6 y, was evaluated from 1990 to 1998. A total of 57 clinical, serological and therapeutic variables were studied.

Results: Five- and 10-year survival was 91% and 85% respectively. Forty four patients died (12%): 54% due to sepsis and 32% due to active SLE. Mortality risk factors included heart involvement CRR 3.82), hyperlipidemia (RR 2.72), renal damage (RR 2. 62), infections (RR 2.44), lung disease (RR 2.20) and myositis (RR 2. 07). High-dose prednisone (RR 3.4) or cyclophosphamide (RR 9.19) treatments increased the risk of sepsis (P=0.003) as a cause of death. However, corticosteroids, antimalarial agents and accumulated cyclophosphamide doses proved to be protective factors in overall mortality figures (RR <1).

Conclusions: The main risk factors of death in SLE were heart involvement, hyperlipidemia and renal damage. Treatment with steroids, antimalarial agents and cyclophosphamide improved survival. High-dose corticosteroids and cyclophosphamide were associated with sepsis as a cause of death.

PubMed Disclaimer

Publication types